Lake City Medical Center
July 07, 2014

Lake City, FL – Lake City Medical Center announced that it is the first hospital in a tri-county area to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System in a patient, the smallest implantable cardiac monitoring device available.

The LINQ device is approximately one-third the size of a AAA battery (~1 cc), making it more than 80 percent smaller than other ICMs. While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years, with 20 percent more data memory than its larger predecessor.

“The LINQ is a new, smaller technology that helps us to diagnose heart rhythm problems in patients where traditional monitoring doesn’t help us come up with a diagnosis,” said Steven Roark, MD, FACC, cardiologist with The Cardiac & Vascular Institute and member of the Lake City Medical Center medical staff. “The advantages of this implant are that it’s very minimally invasive to the patient, it’s a simple procedure and the device will last up to three years to capture rhythm problems.”

Placed just beneath the skin through a small incision of less than 1 cm in the upper left side of the chest, the Reveal LINQ ICM is often nearly invisible to the naked eye once inserted. The device is placed using a minimally invasive insertion procedure, which simplifies the experience for both physicians and their patients. The Reveal LINQ ICM is MR-Conditional, allowing patients to undergo magnetic resonance imaging (MRI) if needed.

In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink® Network. Through the Carelink Network, physicians can request notifications to alert them if their patients have had cardiac events. The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitation, syncope (fainting) and chest pain that may suggest a cardiac arrhythmia, and for patients at increased risk for cardiac arrhythmias.

The Reveal LINQ system also includes the new MyCareLink ™ Patient Monitor, a simplified remote monitoring system with global cellular technology that transmits patients’ cardiac device diagnostic data to their clinicians from nearly any location in the world.

“Having this type of technology available to residents of Lake City and the surrounding communities is huge,” said Mark Robinson, CEO of Lake City Medical Center. “This is just another example of how joining forces with our sister hospital, North Florida Regional Medical Center, allows us to bring additional physician expertise to our community. It benefits our patients by offering access to new technologies close to home.”